Metabolic networks are extensively regulated to facilitate tissue-specific metabolic programs and robustly maintain homeostasis in response to dietary changes. Homeostatic metabolic regulation is achieved through metabolite sensing coupled to feedback regulation of metabolic enzyme activity or expression. With a wealth of transcriptomic, proteomic, and metabolomic data available for different cell types across various conditions, we are challenged with understanding global metabolic network regulation and the resulting metabolic outputs. Stoichiometric metabolic network modeling integrated with "omics" data has addressed this challenge by generating nonintuitive, testable hypotheses about metabolic flux rewiring. Model organism studies have also yielded novel insight into metabolic networks. This review covers three topics: the feedback loops inherent in metabolic regulatory networks, metabolic network modeling, and interspecies studies utilizing Caenorhabditis elegans and various bacterial diets that have revealed novel metabolic paradigms.
INTRODUCTION MECHANISMS OF METAZOAN NUTRIENT SENSING AND METABOLIC REGULATION
To maintain metabolic homeostasis, cells must monitor their energy states, the quantities of central chemical building blocks, and essential micronutrients. This information enables the cell to take the most appropriate action given its metabolic circumstances, whether that means a subtle shift in oxidative fuel choice or a dramatic rewiring of the metabolic network in response to starvation or hypoxia. How do cells sense the diverse repertoire of metabolites, and how do they use this information to make regulatory decisions? Organisms have evolved complex networks of proteins with metabolite-sensing capabilities that relay information about the concentrations of key metabolites to regulators or that are themselves direct regulators of metabolic genes. Metabolite sensing is achieved in large part through physical interactions between metabolites and regulators that can affect the function of a regulator by altering its biophysical properties. Many nutrient-sensing regulators are transcription factors and members of signal transduction pathways that regulate metabolic enzyme expression and function at various levels.
Metabolic regulation utilizes negative feedback loops (nFBLs), which are known to confer the properties of robustness (80) and adaptability (93, 96) to biological networks. nFBLs in metabolism center on metabolites, which need to be maintained within proper cellular concentrations. Metabolic nFBLs include additional components such as enzymes to modify metabolite concentrations, regulators to regulate enzyme expression or activity, and sensors to monitor metabolite levels (81) . For example, the cellular ATP control system operates as an nFBL to maintain appropriate energy levels (Figure 1) . In this system, AMP:ATP ratios are sensed by AMPK, which serves both sensor and regulator functions. AMPK is activated by increased AMP:ATP levels and phosphorylates glycolytic enzymes among other metabolic targets to enhance glycolytic flux, ultimately increasing ATP production. As ATP levels increase, AMPK is inhibited, which completes the feedback loop. This section describes how specific metabolic control systems are encoded by the genome, detailing the gene networks responsible for nutrient sensing and metabolic gene regulation as well as the mechanisms they employ.
Glucose Sensing
The insulin-signaling pathway is the major regulator of circulating glucose concentrations and glucose metabolism. It forms a multiorgan nFBL, which is initiated by glucose uptake in pancreatic β-cells. These cells express GLUT2, the highest affinity glucose transporter, and thus are the first cells to be affected by blood glucose spikes after a meal (41) . Glucose is metabolized via glycolysis, the tricarboxylic acid (TCA) cycle, and ultimately the electron transport chain, resulting in increased intracellular ATP:ADP ratios (63) . This leads to depolarization of the cell through inhibited potassium export from ATP-sensitive potassium channels, which causes an influx of calcium and the release of insulin to the bloodstream through exocytosis of insulin-storage granules (63) . Thus, pancreatic β-cells sense an increase in glucose by monitoring their own internal glucose oxidation flux, reflected by ATP:ADP ratios. The release of insulin from the β-cells signifies to other tissues that glucose is abundant and should be imported, metabolized, and/or stored (as glycogen).
In the target tissue, the insulin-signaling pathway initiates with binding of insulin to the insulin receptor, followed by phosphorylation of PI3K and AKT kinase, which are involved in transducing the signal (23) . AKT activates GLUT4 translocation to the cell surface to promote glucose import (76) , inhibits a negative regulator of glycogen synthase (GSK3) to increase glycogen production and thus glucose storage (34) , and inhibits FOXO to halt transcriptional activation of gluconeogenesis enzymes (27, 115) . Glucose, therefore, through its proxy signal Feedback loops in metabolic network regulation. Feedback loops can consist of small molecules (triangles), regulators (squares), and enzymes or other metabolic gene targets (circles). Edges from metabolites to regulators indicate a repressive (red ) or activating ( green) effect of a metabolite on regulator function, with the sensing mechanism noted along the edge. Edges from regulators to enzymes or metabolic genes indicate a repressive (red ) or activating ( green) effect on target function. Edges are marked P to indicate phosphorylation and T to indicate transcription. Edges from enzymes/metabolic genes to metabolites indicate a consuming (red ) or producing ( green) relationship.
insulin, activates its own uptake and storage as glycogen, and inhibits its own biosynthesis by inhibiting gluconeogenic enzyme expression via FOXO inhibition (Figure 1) . The glucose control system maintains blood glucose within a certain range; however, this set point is adjustable (to accommodate periods of feast and famine), and this adjustable set point is particularly prone to dysregulation, leading to obesity, metabolic syndrome, and diabetes (81) .
Amino Acid Sensing
The mammalian target of rapamycin (mTOR) kinase is a major regulator of protein synthesis, autophagy, cell proliferation, and organ size (99) . mTOR provides a link between amino acid availability and translation rates (79) , as mTOR activation by amino acids leads to inhibition of a repressor of translation, eukaryotic initiation factor 4E-binding protein (eIF4E-BP1), and activation of the translational activator S6 kinase (S6K1) (61, 67) . The mechanisms by which amino acids are sensed to regulate mTOR activity are still being elucidated (5). mTORC1, one of two major mTOR complexes, is regulated by the lysosome-bound GTPase Rheb. Under amino acid depletion, inactive mTORC1 is located diffusely throughout the cytoplasm, whereas when amino acids are abundantly present, active mTORC1 is found at the lysosomal surface where it can access the activator Rheb (129) . The most potent amino acid activators of mTORC1 are leucine, arginine, and glutamine, which activate mTORC1 by different mechanisms. In addition to the lysosomal amino acid-sensing mechanism, leucine sensing may be achieved through interactions between leucyl-tRNA synthase and the mTOR complex (56) , whereas glutamine sensing involves the adenosine diphosphate ribosylation factor-1 (Arf1) (73) , and arginine sensing requires the lysosomal SLC38A9 transporter (150) .
Another mechanism of amino acid sensing is the monitoring of uncharged tRNAs, which represent amino acid depletion. This is accomplished through the highly conserved Gcn2-eIF2α-Gcn4/ATF system. As amino acid levels decline during amino acid starvation, uncharged tRNAs accumulate and bind Gcn2 through a domain with homology to histidyl tRNA synthetase. This domain has higher affinity for uncharged tRNA than charged tRNA, and binding causes a conformational change that activates the kinase domain of Gcn2. Gcn2 phosphorylates eIF2α, resulting in a global decrease in translation rates, with the exception of certain mRNAs, such as those encoding the transcription factors Gcn4 and ATF. Transcriptional targets of Gcn4 include amino acid biosynthetic enzymes and transporters (65) . ATF drives the autophagy gene expression program in order to salvage amino acids from existing proteins (8) .
Lipid Sensing
We focus on the mechanisms for sensing two types of lipid: cholesterol and free fatty acids. Cholesterol is an important component of mammalian cell membranes and also serves as a precursor in the synthesis of bile acids and steroid hormones. Cholesterol sensing takes place in the endoplasmic reticulum membrane, where SREBP, a transcription factor, resides with its binding partners SCAP and Insig1 (39) . When cholesterol levels in the membrane fall below a threshold, Insig1 dissociates, and the SCAP-SREBP complex translocates to the Golgi body, where SCAP-activated S1P and S2P proceed to cleave SREBP, freeing SREBP to migrate to the nucleus (125, 151) . Once in the nucleus, SREBP activates the transcription of several genes in the de novo cholesterol biosynthesis pathway, including HMG-CoA reductase (68) , the target of widely used cholesterol-lowering statin drugs. Thus, via SREBP, cholesterol negatively regulates its own biosynthesis.
Fatty acids consist of saturated and unsaturated carbon chains with a carboxylic acid head group. Fatty acids serve both structural (as components of cellular membranes) and energy-storage purposes (in their acyl-CoA form). The precise sensing mechanisms for different fatty acids are not entirely clear, but it has been suggested that the peroxisome proliferator-activated receptor (PPAR) subgroup of nuclear hormone receptors sense the fatty acid milieu of the cell through promiscuous, weak binding of diverse fatty acid ligands (20, 147) . The binding affinities observed in vitro [2-50 μM range for PPARα binding to free fatty acids (146) ] may indicate that PPARs are activated only when ligands reach high concentrations in vivo (128) . PPARs regulate the expression of enzymes involved in fatty acid oxidation (78) , and increased intracellular levels of fatty acids result in increased PPAR-mediated expression of fatty acid oxidation genes (108) . Another nuclear receptor, HNF4-α, also binds lipids and regulates an overlapping set of lipid metabolism genes. Therefore, free fatty acids activate their own oxidation through PPARs and HNF4-α.
Nucleotide Sensing
Nucleotide pools are carefully managed, as nucleotide deficiencies lead to increased mutagenesis rates and genomic instability (12) . During S phase, the demand for nucleotides spikes to support DNA replication, and enzymes involved in de novo nucleotide biosynthesis are transcriptionally upregulated, including ribonucleotide reductase (RNR) (13) , which converts nucleoside diphosphates (NDPs) to deoxynucleoside diphosphates (dNDPs); these go on to form deoxynucleoside triphosphates (dNTPs). RNR and other nucleotide metabolism genes are direct targets of c-MYC, a master transcriptional regulator of the cell cycle (90) . RNR is subject to further regulation through subcellular localization [for instance, it assembles at sites of DNA damage (141) ], proteolytic degradation (19) , and an elegant system of allosteric feedback with various end product dNTPs to ensure proper nucleotide ratios (66) . This autoregulation occurs via differential binding of ATP, dATP, dTTP, and dGTP to the specificity site, or S site. The identity of the S site-bound nucleotide dictates the substrate preference of RNR: ATP and dATP binding stimulates conversion of CDP to dCDP, dTTP (which is formed from dCTP through the de novo nucleotide synthesis pathway) activates conversion of GDP to dGDP, and finally dGTP activates conversion of ADP to dADP. When dATP levels are high, dATP binds a different site on RNR, the A site, to shut down all RNR activity and halt dNTP synthesis. Thus, RNR plays multiple vital roles in maintaining proper nucleotide pools; it is the enzyme that creates dNTPs, the sensor of dNTP ratios, and the regulator of those ratios.
Trace Element Sensing: Zinc
Trace metals, including cobalt, iron, and zinc, are micronutrients that function extensively throughout the metabolic network, where they bind enzymes to form metalloenzymes, which utilize bioinorganic chemistry to catalyze metabolic reactions that are difficult to achieve with organic chemistry alone. Trace metals are important resources that must be extracted from the diet and carefully incorporated into the cellular economy to avoid the toxicity associated with the overabundance of highly reactive free ions. However, deficiencies in trace elements can be catastrophic for an organism, as they can impair the function of hundreds if not thousands of different proteins.
For instance, zinc is predicted to bind 10% of the human proteome (4), serving both catalytic and structural roles. As a structural component, it generates protein-folding landscapes, which increases the complexity of protein-protein and protein-DNA interactions (101) . In human metabolism, the catalytic activity of zinc is used by >100 zinc metalloenzymes (103) . A classic example is carbonic anhydrase, which accommodates a zinc atom in its reaction center and reversibly converts carbon dioxide to bicarbonate (139) .
An intricate network of zinc importers and exporters, intracellular zinc binding/transporting metallothioneins, and zinc-sensing transcription factors such as MTF-1 (25) regulate the cellular reservoir of zinc ions. As with the other nutrient-sensing mechanisms, zinc sensing involves nFBLs to maintain zinc pools within an optimal cellular threshold. MTF-1, itself a zinc-finger protein, transports to the nucleus upon binding free zinc ions in the cytoplasm. In the nucleus, it binds to metal response elements (MREs) and thereby activates the expression of zinc-sequestering metallothioneins and zinc exporters. MTF-1 can also repress some targets, including the zinc importer Zip10, which has an MRE downstream of its transcription start site, and binding of MTF-1 to this MRE stalls Pol II progression (54) . Whereas MTF-1 is conserved from insects to mammals, there is no clear ortholog in the nematode C. elegans. C. elegans does exhibit transcriptional responses to zinc and a C. elegans zinc-responsive DNA element was recently identified (122) . However, the transcription factor responsible for sensing zinc and binding this element is still unknown.
Vitamin Sensing
Vitamins are chemical cofactors required for the proper functioning of a species (the vitamin auxotroph) but provided by another species (the vitamin synthesizer). Vitamin auxotrophy is a cornerstone of many symbiotic relationships (33, 62) , including the relationship between humans and the vitamin-producing bacteria that make up our microbiota (84) . Humans require a suite of vitamins that function in diverse metabolic pathways, and flux through these pathways inherently depends on the quantity of vitamins derived from diet and provided by our microbiota. Vitamin deficiencies were once a major cause of disease and death in human populations, and continue to cause health problems in underdeveloped countries. In mammals, direct sensing of vitamin A and vitamin D occurs through binding to nuclear hormone receptors. Vitamin D, which is technically a hormone rather than a vitamin given that it can be synthesized from cholesterol in the skin upon UV light exposure, regulates the uptake of calcium, iron, magnesium, and zinc (59) . This regulation occurs through vitamin D receptor (VDR)-mediated transcriptional activation of the transporters of these micronutrients (18) . Vitamin A, a true vitamin, has a plethora of functions in diverse processes, including development, vision, and immunity (38) . Vitamin A does not function in anabolic or catabolic processes, as most other vitamins do, but rather serves as a light-sensing cofactor for rhodopsin and a signaling morphogen to regulate Hox genes during development via retinoic acid receptor (RAR) binding (38) . There are enzymes that modify dietary Vitamin A (retinol) to generate retinal (the form utilized by rhodopsin) and retinoic acid (the form that directly binds and activates RAR), as well as enzymes that degrade retinoic acid. Vitamin A metabolism is tightly regulated by positive and negative FBLs to maintain proper concentrations of the various forms of Vitamin A during development, given that dysregulation can lead to teratogenesis (35, 134) . For instance, the retinoic acid-degrading enzyme CYP26A1 is directly activated by RAR through binding of highly conserved retinoic acid response elements (RAREs) in its promoter (35) . Thus, retinoic acid activates its own degradation, preventing deleteriously high levels of retinoic acid from building up. Retinoic acid also represses the expression of the enzymes involved in its synthesis from retinol, although the mechanisms of this repression are unknown (35) .
Less is known about the mechanisms employed by mammalian cells to sense other vitamins, if they do exist. However, gene expression studies have revealed regulatory responses to vitamins B1 (thiamine) (47, 88, 142) , B2 (riboflavin) (111), B3 (nicotinamide/niacin) (26, 29, 50) , B6 [pyridoxal 5 phosphate (PLP)] (145, 158), B9 (folic acid) (7, 21, 87) , C (ascorbic acid) (17, 74, 140) , and E (tocopherol/tocotrienols) (83, 100, 110) . Indirect vitamin-sensing mechanisms, in which flux through the vitamin-dependent pathway is sensed as a proxy for vitamin abundance, may also exist. For instance, the nematode C. elegans exhibits a vitamin B12 response in which the expression of several metabolic genes is tuned according to dietary vitamin B12 intake. However, genetic perturbation of either of the two vitamin B12-dependent pathways disrupts the vitamin B12 responsiveness of several of these genes (154) . This demonstrates that vitamin B12 itself is not the mediator of transcriptional changes but rather suggests that some genes are regulated according to flux through vitamin B12-dependent pathways rather than the absolute quantities of the vitamin. Several C. elegans nuclear hormone receptors are implicated in this response (153) , although the identities of the metabolites that are sensed remain to be identified.
Energy Sensing
As the energy currency of the cell, ATP is a vital molecule required by many diverse cellular processes. A central regulator of energy homeostasis is AMPK, a heterotrimeric kinase that senses AMP/ATP ratios and regulates ATP production accordingly. AMPK is activated by high AMP levels and inhibited by high ATP levels (58). As energy is harvested from the hydrolysis of ATP to ADP, increasing ADP levels push the adenylate kinase reaction (2ADP ↔ ATP + AMP) toward AMP and ATP production to buffer the falling ATP levels. AMPK activity increases severalfold in vitro when AMP is present (24) , and increases more than 100-fold when phosphorylated by its upstream regulator, the LKB1-STRAD-MO25 complex (60) . Although this complex does not sense AMP itself, it phosphorylates AMPK preferentially when AMP/ATP ratios are high because of conformational changes in AMPK induced by AMP or ADP binding, which enhances phosphorylation site availability (156) . There are many downstream targets of AMPK, including the central carbon metabolism enzymes 6-phosphofructo-2-kinase (glycolysis enzyme activated by AMPK phosphorylation) and acetyl-CoA carboxylase (fatty acid synthesis enzyme inhibited by AMPK). The end result of AMPK activation is enhanced oxidative catabolism of glucose and fatty acids to fuel the electron transport chain to produce more ATP, and the inhibition of anabolic pathways such as gluconeogenesis and fatty acid synthesis (106) .
Oxygen Sensing
Cellular oxygen levels must be closely monitored, as major metabolic network rewiring must take place to survive periods of hypoxia. Primarily, a shift from oxidative phosphorylation (OXPHOS) to anaerobic glycolysis is needed for compensatory ATP production. The chief oxygen sensor, conserved in all metazoans, is the prolyl-hydroxylase and hypoxia-inducible factor 1 (HIF-1) system. HIF-1 is a heterodimeric transcription factor, consisting of a basic helix-loop-helix DNA binding domain, a heterodimerization domain, and a transcriptional coactivator-binding domain. Under normoxic conditions, HIF-1 is hydroxylated by prolyl-hydroxylases (42), leading to ubiquitination by a von Hippel-Lindau-guided E3 ubiquitin ligase (116) and proteasomal degradation of HIF-1 (127) . Under hypoxic conditions, the prolyl-hydroxylases fail to hydroxylate HIF-1 because this reaction requires molecular oxygen, and the HIF-1 protein is stabilized (130) . Stable, active HIF-1 accumulates in the nucleus, where, in addition to upregulating the expression of proangiogenic factors like vascular endothelial growth factor (VEGF) to increase oxygen flow (89) , it activates expression of glycolytic enzymes (133) , resulting in increased flux through glycolysis to compensate for the lack of mitochondrial ATP production.
The HIF-regulating prolyl-hydroxylases are Fe, O 2 , and α-ketoglutarate (α-KG, a TCA cycle intermediate) dependent, suggesting that the HIF-1 oxygen-sensing system also senses and responds to changes in iron and α-KG levels through altered prolyl-hydroxylase substrate availability (95) . A lack of α-KG may signify reduced flux through the TCA cycle, and therefore an impending energy crisis, given that the TCA cycle produces reducing equivalents to fuel OXPHOS. Low TCA cycle flux and a lack of O 2 would therefore lead to a decrease in ATP production via OXPHOS and, in either situation, the HIF-1-mediated increase in glycolytic flux provides necessary compensation. Aberrant activation of HIF-1 under normoxic conditions is a common occurrence in cancer cells and helps establish the aerobic glycolysis metabolic program conducive to rapid proliferation (102, 121, 132) .
Intercommunication Between Metabolic Regulatory Pathways
Regulatory cross talk between the various metabolite-specific sensing pathways is a useful way for the organism to coordinate metabolism with growth or to cope with nutrient stress. For instance, the insulin-signaling cascade activates mTOR to promote protein synthesis and cell growth. However, under nutrient stress, mTOR is inhibited by AMPK to slow translation rates and halt cell growth and proliferation. Below are several examples of cross talk between pathways.
The insulin-signaling pathway activates mTOR through AKT-mediated inhibition of TSC1/TSC2, the major mTOR repressor (69) . mTOR is inhibited by AMPK, both directly through phosphorylation of Raptor (55) and indirectly through activation of mTOR repressors TSC1 and TSC2 (70) .
AMPK activates FOXO (53) , which upregulates genes involved in gluconeogenesis, lipid metabolism, and autophagy. (57) . mTOR can activate SREBP-1 (119) through Lipin-1 (118) to activate lipid synthesis for cell growth and proliferation. AMPK directly phosphorylates SREBP-1 to inhibit its cleavage and translocation into the nucleus, thus repressing SREBP-1-mediated transcriptional activation of lipid synthesis in mammalian liver (85) .
BUILDING METABOLIC NETWORK MODELS AND INCORPORATING "OMICS" DATA
Metabolic regulation targets genes that encode metabolic enzymes or transporters. The output of this regulation is altered metabolic flux in regulated reactions and pathways, known as metabolic network rewiring. A major challenge is to interpret local metabolic network rewiring in the context of the entire metabolic network and to decipher how these rewiring events affect overall phenotypic outputs. To address this challenge, it has become prudent to reconstruct and mathematically model global metabolic networks for major model organisms and humans. In the following section, we first summarize the general principles of metabolic network reconstruction and modeling, and then discuss the application of human metabolic models to the generation of tissue-and conditionspecific metabolic networks and to the resolution of metabolic changes associated with disease.
Building Mathematical Models of Genome-Scale Metabolic Networks
Reconstruction of a metabolic model begins with annotation of gene-protein-reaction (GPR) associations from the literature and from bioinformatic analysis of gene sequences (131) . Reaction sets for annotated enzymes are derived from several databases, including Brenda (131) and KEGG (75) . Boolean language (AND, OR) is used to describe GPRs. For instance, if two isozymes can catalyze the same reaction, they are associated with OR logic to that reaction, and enzyme complex subunits that work in concert but are encoded by different genes are associated to their reaction with AND logic (143) . Although most metabolic network modeling efforts to date have targeted microorganisms (44), genome-scale reconstructions have also been built for several metazoans, including humans (40, 92, 144) , mouse (138) , Arabidopsis (37), and zebrafish (10) . The most recent reconstruction of the human metabolic network is based on 1,789 enzyme-encoding genes, with a total of 7,440 reactions annotated, including those that transport metabolites between eight compartments and involving 2,626 unique metabolites (144) . An ideal metabolic model can take the composition of nutrients from diet as input and generates as output a range of flux distributions that satisfy experimentally determined measurements of biomass composition and energy requirements of the organism. This is mathematically achieved by representing the network as a stoichiometry (S) matrix that consists of the coefficients of metabolites (rows) in corresponding reactions (columns), such that these coefficients are negative for the reactants and positive for the products of a given reaction (see the toy network in Figure 2a ). This matrix is multiplied by a vector of fluxes (v), and the equation is set to equal zero, representing mass balance under steady state conditions (i.e., at every compound node, the total flux of consumption matches that of production). The solution of this equation alone gives the null space of the S matrix. To narrow down the solution to a biologically meaningful space of feasible fluxes, a set of reaction constraints are applied based on available information of the biochemistry. In particular, irreversible reactions are limited by a lower boundary of zero, i.e., flux in the reverse direction is disallowed. In addition, an objective function is set to obtain a particular flux distribution within this biological solution space to achieve a defined goal, such as the maximization of growth (i.e., the flux of a biomass assembly reaction) or maximization of energy generation. This method is referred to as constraint-based flux balance analysis (FBA) (136) . Importantly, after typical constraints are imposed, the same objective may still be achieved by multiple flux distributions, which implicates the existence of alternate pathways (Figure 2a Then, additional constraints based on experimental data, such as gene expression levels informing whether a subset of reactions carry flux or not, can be utilized to narrow down the solution space further by eliminating or favoring some of the alternative pathways (Figure 2b) .
Using "Omics" Data to Extract Tissue-and Condition-Specific Metabolic Network Models
One way to address the regulation of metabolic networks is to extract from the generic metabolic network of an organism the metabolically rewired states that are tightly regulated, for instance, in different tissues or under specific conditions. Current methods of extraction constrain the global network models with tissue-or condition-specific experimental evidence, including gene expression data (Figure 2b) . For instance, mixed integer linear programming was used to penalize FBA for introducing flux in reactions associated with lowly expressed genes and for lack of flux in reactions associated with highly expressed genes, and this way, flux distributions in 10 human tissues were predicted based on transcriptomic and proteomic data sets (136) . A more advanced and systematic optimization procedure called the model-building algorithm (MBA) was later developed to take into account not only expression data but also other tissue-specific information, such as phenotypic data and the presence of tissue-specific metabolites (71) . This method uses sets of reactions grouped according to their probability of being functional in the targeted tissue based on experimental information, and optimizes the metabolic network to maximize the number of reactions in higher probability categories while minimizing those that are unlikely to be present. MBA was successfully used to derive a liver metabolic network that outperforms the generic human model in predicting hepatic fluxes in different conditions and changes in biomarkers of hepatic disorders related to metabolism (71) . Several other methods for deriving tissue-specific metabolic networks have been developed and validated since the development of MBA, including GIMME, which uses gene expression data combined with objective functions such as energy generation (9), mCADRE, which is similar to MBA (152), and INIT, which is also similar to MBA with a key exception that it allows flux imbalance to address metabolomics data (2) . More about tissue-specific applications of metabolic network modeling can be found in a recent review (124) .
Constraint-Based Metabolic Models of Cancer
Cancer cells exhibit major metabolic network rewiring in central carbon pathways that allow uncontrolled proliferation. Although the switch from OXPHOS to aerobic glycolysis in cancer cells 
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was first described by Otto Warburg more than 90 years ago, we are still determining its causes and consequences. It seems counterintuitive that rapidly proliferating cancer cells would prefer a less-efficient glucose catabolism with respect to ATP production (i.e., 1 mole of glucose yields 2 moles ATP from glycolysis versus 32 moles ATP from OXPHOS) because proliferating cells still require copious amounts of ATP. Recently, metabolic modeling of human cancer has been applied to explore Warburg-like metabolic rewiring. Cancer metabolic models have accurately predicted a preference for flux through the glycolysis-branching pentose phosphate pathway to supply the cell with reducing equivalents (NADPH) for fatty acid synthesis and nucleotide biosynthesis precursors. Other studies utilizing either small kinetic (148) or global stoichiometric (135) metabolic models of cancer have arrived at the same conclusion, which is that in the context of rapid proliferation, glycolysis alone is actually more energetically efficient than OXPHOS if the costs of enzyme synthesis and molecular crowding are taken into account. By constraining a global stoichiometric model with gene expression data, cancer metabolic models have been built for individual tumors to define metabolic phenotypes of premalignant versus malignant tumors (premalignant models actually supported higher growth rates) and estrogen receptor (ER)+ versus ER− breast cancers (72) .
Metabolic modeling of an engineered fumarase-deficient cell line was used to generate hypotheses that can explain how fumarase-deficient tumors manage to fuel the electron transport chain without a functional TCA cycle (48) . This modeling discovered that these cells compensate for lack of NADH production by synthesizing and degrading heme. Fumarase deficiency leads to a buildup of fumarate, which is believed to act as an oncometabolite by inhibiting prolyl-hydroxylases from activating HIF-1 under normoxic conditions, leading to Warburg-like glucose metabolism and enhanced vascularization via HIF-1-mediated VEGF activation (48) . Whether Warburg-like metabolism is a driver or an enabler of tumorigenesis is a subject of debate. Certainly, many proliferating cells exhibit aerobic glycolysis and do not become tumorigenic. Simultaneously, there is compelling evidence supporting the notion that metabolic disruptions such as fumarase deficiency, succinate dehydrogenase deficiency, and neomorphic mutations in isocitrate dehydrogenase (114) can be oncogenic. Interestingly, these metabolic disturbances are each associated with specific types of cancer, suggesting context dependence for the transformative properties of the putative oncometabolites fumarate, succinate, and 2-hydroxyglutarate. Recently, cancer typespecific metabolic models were built and queried with commonly detected cancer type-specific enzyme mutations to explore the context dependence of known oncometabolites and predict novel oncometabolites, resulting in 15 newly predicted oncometabolites (112) . Another study utilized constraint-based models of tumor cell metabolism to predict novel drug targets by determining cancer-specific synthetic lethal relationships within the metabolic network (46) .
NOVEL PARADIGMS IN METABOLIC NETWORK FUNCTION AND REGULATION FROM CAENORHABDITIS ELEGANS
Although metabolic modeling compiles known metabolic data into a mathematical framework, it has limited ability to predict novel metabolic functions and pathways, and cannot critically assess the assignment of genes to reactions. This was illustrated in a recent study of metabolic models, which found that metabolic network reconstruction similarity between organisms did not correlate well with genome similarity or phylogenetic distance, and often metabolically diverse organisms had highly similar metabolic network models (107) . This is largely due to the fact that metabolic models are often built upon the framework of an existing model (107) , and reactions and pathways outside of common central metabolic pathways are largely unexplored in most species, biochemically or genetically. Advancement in metabolic modeling will require complementary efforts in biochemistry and genetics to expand our knowledge about metabolism. Here, we focus on recent studies that have taken advantage of the genetic tractability of the nematode C. elegans to generate novel insights into metabolic gene function and regulation.
Caenorhabditis elegans Genetics Identify Novel Enzyme Activities and Biological Significance
C. elegans is a bacterivorous soil-dwelling nematode, consisting of 959 somatic cells, whose short life cycle (3 days) and genetic tractability make it amenable to high-throughput genetic screening. Much of the human metabolic network is conserved in C. elegans, which also has similar essential nutrient requirements, devoted metabolic tissues (primarily the intestine, comprising 20 cells), and conserved metabolic regulatory pathways such as the insulin and TOR signaling pathways (14) . In fact, the regulation of FOXO by insulin signaling and its relationship to aging were identified in C. elegans (115) , as was the regulation of HIF-1 by prolyl-hydroxylases (42) .
C. elegans can be used to genetically dissect metabolic phenotypes and explore metabolic enzymes of unknown function. For instance, ACER-1, a conserved protein of unknown function, was identified as a novel acetyl-CoA hydrolase (converting acetyl-CoA into acetate and CoA) in a search for binding partners of CRA-1, a conserved regulator of global histone acetylation, which functions by an unknown mechanism (49). ACER-1 was found to bind and affect CRA-1-regulated histone acetylation, and metabolomics revealed elevated acetyl-CoA levels in an acer-1 mutant. Thus, a mechanism was proposed whereby CRA-1 regulates the levels of acetyl-CoA in the nucleus and thus histone acetylation by antagonizing ACER-1 acetyl-CoA hydrolase activity (49) Other studies have identified new biological roles for known enzymes and have revealed novel relationships between metabolic pathways and cellular processes. For instance, mutation of tyrosine aminotransferase (tatn-1; breakdown of tyrosine to acetoacetate and fumarate) resulted in gene expression changes and enhanced the lifespan extension of insulin-signaling mutants (45) . These effects were largely due to elevated tyrosine levels, which activated AMPK to repress FOXO (daf-16) (45) . Another study identified a diet-specific phenotype for the proline catabolic enzyme alh-6, which is the ortholog of human 1-pyrroline-5-carboxylate (P5C) dehydrogenase (P5CDH). alh-6 mutants exhibited reduced lifespan on the standard laboratory diet of Escherichia coli OP50 but on a diet of E. coli HT115 alh-6 mutants and wild-type animals exhibited identical lifespans (117) . The specific metabolic differences between these two E. coli strains as they relate to the lifespan of the alh-6 mutant are unknown, although metabolomic profiling has revealed myriad differences in metabolite levels. The buildup of the alh-6 substrate P5C was proposed to be the cause of premature aging in the mutant because knockdown of the upstream enzyme proline dehydrogenase, which produces P5C from proline, rescued some of the effects of the alh-6 mutant on aging (117) . Thus, a novel role for proline catabolism in metabolic flexibility, healthy aging, and adaptation to dietary changes was established, although the mechanisms underlying these roles are unknown.
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Caenorhabditis elegans Genetics Reveal Factors Involved in Metabolic Response to Diet and the Microbiota
Diet and microbiota composition have profound impacts on host metabolic network regulation and function; however, these impacts are difficult to investigate because of the complexity and diversity of dietary inputs, as well as the genetic complexity and diversity within the human population and microbiota. A major advantage of using C. elegans is the ability to genetically dissect the regulatory mechanisms that enable metabolic network rewiring in response to changes in the bacterial diet and the resulting physiological outputs. For instance, C. elegans has been used extensively to study the effects of caloric restriction on metabolism and lifespan, and more recently to delineate regulatory networks controlling metabolic responses to dietary composition. The genetic tractability of both C. elegans and its bacterial diets renders this natural predator-prey system an excellent model to study the principles of metabolic network regulation in response to diet, as well as to model the effects of commensal bacteria on host metabolism and physiology (16, 97, 157) . Recently, it was discovered that the lifespan-extending effect of the antidiabetic drug metformin on C. elegans is due to alteration of E. coli folate metabolism, which affects flux through the folate-dependent one-carbon cycle in C. elegans, as demonstrated through genetic inactivation of C. elegans onecarbon-cycle genes (15) . Another study serendipitously isolated a spontaneous mutation in E. coli aroD, a shikimic acid pathway gene required for folate precursor biosynthesis, when screening an RNAi feeding library for C. elegans lifespan extension (149) , further demonstrating the link between microbial folate production and C. elegans longevity.
C. elegans has been fed a variety of metabolically diverse bacterial species in the lab, and the physiological and gene expression responses in C. elegans have been measured (28, 98) . In one study, many of the genes that exhibit diet-induced expression changes were found to confer diet-specific phenotypes when mutated (28) . Genetic inactivation of the regulators of metabolic gene expression can also confer diet-specific phenotypes. For instance, mutations in the nuclear hormone receptor nhr-114 lead to complete sterility caused by a defective germline on a diet of E. coli OP50; however, nhr-114 mutants develop intact germlines and are fertile when fed E. coli HT115 (52) . As with the alh-6 example, the differences between E. coli OP50 and HT115 that determine nhr-114 sterility are unknown, although supplementation of E. coli OP50 with tryptophan could rescue the nhr-114 sterility phenotype on this diet (52) . A challenge for the future will be to determine the causal factors among a sea of differences in nutrient compositions between different bacterial diets that drive effects in the animal.
Recently, interspecies genetics has been used to address this very challenge. Genetic screening in both C. elegans and its bacterial diets, Comamonas aquatica and E. coli, revealed bacterially produced vitamin B12 as the driver of several C. elegans gene expression and physiological changes (154) . These screens employed a transgenic C. elegans reporter strain, in which green fluorescent protein expression is driven by the promoter of the C. elegans gene acdh-1, which is strongly repressed by the Comamonas diet but activated by the E. coli diet (98) . Mutations in Comamonas vitamin B12 biosynthetic enzymes were identified in strains that failed to repress acdh-1 promoter activity. Exogenous supplementation of B12 was sufficient to repress acdh-1 expression on the low-B12 diet of E. coli OP50. Networks of C. elegans metabolic and regulatory genes, including nuclear hormone receptors, were required for the repression of the acdh-1 promoter by the vitamin B12-synthesizing Comamonas diet (153) . Interestingly, the vitamin B12-mediated repression of acdh-1 was dependent on flux through the vitamin B12-requiring propionate breakdown pathway, as mutants in this pathway resulted in constitutively activated acdh-1 expression (154) . These genes could also be activated by exogenously supplied propionate, and deletion of acdh-1 increases sensitivity to propionate-induced toxicity (154) , suggesting that this gene may be involved in novel Dissecting diet-related phenotypes in Caenorhabditis elegans with interspecies genetics. To determine gene networks involved in dietrelated phenotypes in C. elegans, genetic screens can be performed in both the bacterial diet and in the animal. C. elegans can be fed a library of mutant bacteria to determine bacterial genes that, when mutated, lead to a particular phenotype. To identify C. elegans genes that are involved in the diet-associated phenotype, animals can be fed a library of dsRNA-expressing bacteria targeting individual C. elegans genes. Hits from either screen should be retested and validated, and can be built into gene networks based on coexpression, cocomplex formation, and/or genetic interaction data, or metabolic pathway annotations. Hypotheses about interspecies gene network interactions and their consequences with respect to the metabolic phenotype can be generated and further tested.
alternative propionate breakdown or detoxification mechanisms on low-B12 diets. This approach utilizing interspecies systems biology serves as an example of how the effects of nutrient composition within complex biotic diets on animal gene expression and physiology can be elucidated (Figure 3) .
CONCLUSIONS AND FUTURE DIRECTIONS
Metabolic network modeling can benefit from improvements both in the biological knowledge that is integrated into the model and in the computational methods of such integration (107) . Although utilization of gene expression data to predict condition-specific fluxes has been advanced by numerous methods (94, 112) , techniques to integrate many other types of data sets of potential importance are in the early stages. In particular, methods that constrain FBA with metabolomics data are emerging (148) . Other challenges include the integration of kinetic parameters and metabolite concentrations. Kinetic parameters of central carbon pathways have been incorporated into the E. coli model (32) . Certain human pathways, such as the one-carbon cycle (113) , have also been studied using kinetic models equipped with experimentally determined parameters. Thus, it is reasonable to expect the integration of kinetic data into genome-scale models of metazoan metabolism. Perhaps the greatest future challenge for genome-scale metabolic network modeling with the greatest potential benefit is the direct incorporation of regulatory networks (such as the regulatory nFBLs discussed in this review) into the model. An existing method named regulatory FBA converts gene regulatory pathways to a Boolean formalism that dictates "on" or "off " states of reactions within stoichiometric metabolic network models (31) . This technique has been used to incorporate regulatory networks of E. coli (30) and yeast (64) into the respective genome-scale network models. Other Boolean formalism-based methods (6, 22, 32, 43, 51, 137) , as well as a novel stochastic approach (22) , have also been developed, but applications have been limited to microorganisms to date. Direct integration of metazoan regulatory networks into genome-scale metabolic models will likely await better characterization of the paths from regulators to enzymatic reactions, which is dependent on protein-metabolite, protein-protein, and protein-DNA interactions.
Recently, our lab has reconstructed a global metabolic network model for C. elegans (L.S. Yilmaz & A.J.M. Walhout, in preparation). C. elegans provides a unique opportunity to rapidly test hypotheses generated by in silico FBA of the metabolic model, such as pathway usage on different diets. Genetic screening in C. elegans can be used to improve GPR annotations and, by extrapolation, guide improvement of annotations within the human model.
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